Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Electrocardiogram (ECG) Devices, Implantable Loop Recorders (ILR), Cardiac Output Monitoring (COM) Devices, Event Monitors, Pacemakers, Cardiac Resynchronization Therapy (CRT) Devices, Defibrillators, and Ventricular Assist Devices (VADs)) and by End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022
- ALL885778
- 318 Pages
- December 2016
- Medical Devices
Cardiac monitoring refers to continuous examination of cardiac activity with the help of some devices, generally an electrocardiogram (ECG). Cardiac monitoring assists a physician to assess a patient’s health with respect to his cardiac rhythm. Cardiac rhythm management devices maintain cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. Both, cardiac monitoring as well as cardiac rhythm management devices help in treatment of cardiac patients ensuring that the patient has a well-functioning heart. These devices play a crucial role to cure and monitor several serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others.
Global cardiac monitoring & cardiac rhythm management market was valued at $19,397 million in 2015 and is expected to reach $32,216 million by 2022, growing at a CAGR of 7.6%. The volume market is poised to grow at a CAGR of 13.6% from 2016 to 2022. The market is driven by factors such as growing incidence of cardiac disorders, new technological advancements in cardiac monitoring & cardiac rhythm management devices, awareness among patients about monitoring of the heart and treatment options for management of cardiac disorders and increasing number of unmet medical needs in developing and underdeveloped countries. However, the market is hampered by limited insurance coverage and high cost of these devices (especially in developing nations) and preference for pharmaceutical interventions (drugs) and medications over treatment devices. Conversely, development of new MRI-labeled devices and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.
The report segments the market based on product, end user, and geography. Based on product, the market is divided into ECG devices, implantable loop recorders (ILR), cardiac output monitoring (COM) devices, event monitors, pacemakers, cardiac resynchronization therapy (CRT) devices, defibrillators, and ventricular assist devices (VADs). The end user segment is categorized into hospitals & clinics, home settings, and ambulatory surgical centers (ASCs). Based on geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Malaysia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Egypt, and rest of LAMEA).
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET
KEY BENEFITS:
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by product helps in understanding the various types of devices used for treatment and monitoring of cardiac patients.
- Competitive intelligence highlights the business practices followed by leading players across various regions.
- Comprehensive analysis of all geographical regions is provided, which helps in determining the prevailing opportunities in these geographies.
- Key players within the market are profiled in the report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global market.
CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET
KEY SEGMENTS:
BY PRODUCT
- Electrocardiogram (ECG) Devices
- ECG by Type
- Resting ECG
- Stress ECG
- Holter Monitors
- Wired
- Wireless
- ECG by Lead
- Single Lead
- 3-6 Lead
- 12 Lead
- ECG by Type
- Implantable Loop Recorders (ILR)
- Cardiac Output Monitoring (COM) Devices
- Minimally Invasive COM Devices
- Noninvasive COM Devices
- Event Monitors
- By Type
- Pre-symptom
- Post-symptom
- By Technology
- Manual Event Monitors
- Autodetect Monitors
- By Type
- Pacemakers
- Implantable Pacemakers
- External Pacemakers
- Cardiac Resynchronization Therapy (CRT) Devices
- CRT-P (CRT with Pacemaker Function)
- CRT-D (CRT with Pacemaker and ICD Function)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDs)
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Dual-chamber ICDs
- Single-chamber ICDs
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- External Defibrillator
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Semiautomated External Defibrillator
- Fully Automated External Defibrillator
- Wearable Cardioverter Defibrillator (WCDs)
- Implantable Cardioverter Defibrillators (ICDs)
- Ventricular Assist Devices (VADs)
- Left Ventricular Assist Device (LVAD)
- Right Ventricular Assist Device (RVAD)
- Biventricular Assist Device (BIVAD)
BY END USER
- Hospitals & Clinics
- Home Settings
- Ambulatory Surgical Centers (ASCs)
BY GEOGRAPHY
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Malaysia
- New Zealand
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Egypt
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Abiomed, Inc.
- Berlin Heart GmbH
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- General Electric Company (GE)
- Hill-Rom Holdings, Inc.
- Jarvik Heart, Inc.
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic plc
- Nihon Kohden Corporation
- ReliantHeart Inc.
- SCHILLER AG
- St. Jude Medical, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
- Siemens AG
- 3M Company
- Asahi Kasei Corporation
- Stryker Corporation
- Mortara Instrument, Inc.
- OSI Systems, Inc.
- Cardionet Inc.
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing incidences of cardiac disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing patient awareness
3.4.1.4. Presence of high-unmet medical needs
3.4.2. Restraints
3.4.2.1. Limited insurance coverage and high cost of devices
3.4.2.2. Preference for drugs
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities in emerging economies
3.4.3.2. Development of new MRI-labeled devices
Chapter: 4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ELECTROCARDIOGRAM (ECG) DEVICES
4.2.1. By type
4.2.1.1. Resting ECG devices
4.2.1.2. Stress ECG devices
4.2.1.3. ECG Holter monitors
4.2.1.3.1. Wired Holter monitors
4.2.1.3.2. Wireless Holter monitors
4.2.2. By lead type
4.2.2.1. Single lead
4.2.2.2. 3-6 lead
4.2.2.3. 12-lead
4.2.3. Key market trends
4.2.4. Key growth factors and opportunities
4.2.5. Market size and forecast
4.3. IMPLANTABLE LOOP RECORDER (ILR)
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. CARDIAC OUTPUT MONITORING DEVICES (COM)
4.4.1. Minimally invasive COM devices
4.4.2. Non-invasive COM devices
4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast
4.5. EVENT MONITORS
4.5.1. By type
4.5.1.1. Pre-symptom
4.5.1.2. Post-symptom
4.5.2. By technology
4.5.2.1. Manual event monitors
4.5.2.2. Autodetect monitors
4.5.3. Key market trends
4.5.4. Key growth factors and opportunities
4.5.5. Market size and forecast
4.6. PACEMAKERS
4.6.1. Implantable pacemakers
4.6.2. External pacemakers
4.6.3. Key market trends
4.6.4. Key growth factors and opportunities
4.6.5. Market size and forecast
4.7. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES
4.7.1. CRT-P (CRT with pacemaker function)
4.7.2. CRT-D (CRT with pacemaker and ICD function)
4.7.3. Key market trends
4.7.4. Key growth factors and opportunities
4.7.5. Market size and forecast
4.8. DEFIBRILLATORS
4.8.1. Implantable cardioverter defibrillators (ICDs)
4.8.1.1. Transvenous implantable cardioverter defibrillator (T-ICDs)
4.8.1.1.1. Single-chamber ICDs
4.8.1.1.2. Dual-chamber ICDs
4.8.1.2. Subcutaneous implantable cardioverter defibrillator (S-ICDs)
4.8.2. External defibrillator
4.8.2.1. Manual external defibrillator
4.8.2.2. Automated external defibrillator (AEDs)
4.8.2.2.1. Semi-automated external defibrillator
4.8.2.2.2. Fully automated external defibrillator
4.8.2.3. Wearable cardioverter defibrillator (WCDs)
4.8.3. Key market trends
4.8.4. Key growth factors and opportunities
4.8.5. Market size and forecast
4.9. VENTRICULAR ASSIST DEVICES (VADS)
4.9.1. Left ventricular assist device (LVAD)
4.9.2. Right ventricular assist device (RVAD)
4.9.3. Biventricular assist device (BIVAD)
4.9.4. Key market trends
4.9.5. Key growth factors and opportunities
4.9.6. Market size and forecast
Chapter: 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS & CLINICS
5.2.1. Market size and forecast
5.3. HOME SETTINGS
5.3.1. Market size and forecast
5.4. AMBULATORY SURGICAL CENTERS (ASCS)
5.4.1. Market size and forecast
Chapter: 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Switzerland
6.3.10. Rest of Europe
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. Malaysia
6.4.8. Australia
6.4.9. New Zealand
6.4.10. Rest of Asia-Pacific
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Egypt
6.5.7. Rest of LAMEA
Chapter: 7 COMPANY PROFILES
7.1. ABIOMED, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves & developments
7.2. BERLIN HEART GMBH
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves & developments
7.3. BIOTRONIK SE & CO. KG
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Key strategic moves & developments
7.4. BOSTON SCIENTIFIC CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves & developments
7.5. CARDIAC SCIENCE CORPORATION
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Key strategic moves and developments
7.6. GENERAL ELECTRIC COMPANY
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves & developments
7.7. HILL-ROM HOLDINGS, INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves & developments
7.8. JARVIK HEART, INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Key strategic moves & developments
7.9. KONINKLIJKE PHILIPS N.V.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves & developments
7.10. LIVANOVA PLC
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves & developments
7.11. MEDTRONIC PLC
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves & developments
7.12. NIHON KOHDEN CORPORATION
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments
7.13. RELIANTHEART, INC.
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Key strategic moves & developments
7.14. SCHILLER AG
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Key strategic moves & developments
7.15. ST. JUDE MEDICAL, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Business performance
7.15.5. Key strategic moves & developments
LIST OF TABLES
TABLE 1. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL ECG DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL ECG DEVICES MARKET, BY LEAD ($MILLION), 2014-2022
TABLE 5. GLOBAL HOLTER MONITORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 6. GLOBAL ECG DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. GLOBAL ECG DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 8. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 10. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 11. GLOBAL CRADIAC OUTPUT MONITORING DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 13. GLOBAL EVENT MONITORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 14. GLOBAL EVENT MONITORS MARKET, BY TECHNOLOGY ($MILLION), 2014-2022
TABLE 15. GLOBAL EVENT MONITORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL EVENT MONITORS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 17. GLOBAL PACEMAKERS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 18. GLOBAL PACEMAKERS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 19. GLOBAL PACEMAKERS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 20. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 21. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 22. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT)DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 23. GLOBAL DEFIBRILLATORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 24. GLOBAL DEFIBRILLATORS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 25. GLOBAL ICDS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 26. GLOBAL EXTERNAL DEFIBRILLATORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 27. GLOBAL AUTOMATED EXTERNAL DEFIBRILLATORS (AED) MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 28. GLOBAL DEFIBRILLATORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 29. GLOBAL DEFIBRILLATORS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 30. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 31. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY REGION ($MILLION), 2014-2022
TABLE 32. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY END USER ($MILLION), 2014-2022
TABLE 33. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 34. HOSPITALS & CLINICS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 35. HOME SETTINGS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 36. AMBULATORY SURGICAL CENTERS (ASCS) CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 37. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 38. NORTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 39. NORTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 40. NORTH AMERICA ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 41. NORTH AMERICA IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 42. NORTH AMERICA CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 43. NORTH AMERICA EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 44. NORTH AMERICA PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 45. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 46. NORTH AMERICA DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 47. NORTH AMERICA VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 48. EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 49. EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 50. EUROPE ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 51. EUROPE IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 52. EUROPE CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 53. EUROPE EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 54. EUROPE PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 55. EUROPE CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 56. EUROPE DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 57. EUROPE VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 58. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 59. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 60. ASIA-PACIFIC ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 61. ASIA-PACIFIC IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 62. ASIA-PACIFIC CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 63. ASIA-PACIFIC EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 64. ASIA-PACIFIC PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 65. ASIA-PACIFIC CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 66. ASIA-PACIFIC DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 67. ASIA-PACIFIC VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 68. LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 69. LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 70. LAMEA ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 71. LAMEA IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 72. LAMEA CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 73. LAMEA EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 74. LAMEA PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 75. LAMEA CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 76. LAMEA DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 77. LAMEA VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 78. ABIOMED: COMPANY SNAPSHOT
TABLE 79. BERLIN HEART: COMPANY SNAPSHOT
TABLE 80. BIOTRONIK: COMPANY SNAPSHOT
TABLE 81. BIOTRONIK: OPERATING SEGMENTS
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 84. CARDIAC SCIENCE CORPORATION: COMPANY SNAPSHOT
TABLE 85. CARDIAC SCIENCE CORPORATION: OPERATING SEGMENTS
TABLE 86. GE: COMPANY SNAPSHOT
TABLE 87. GE: OPERATING SEGMENTS
TABLE 88. HILL-ROM: COMPANY SNAPSHOT
TABLE 89. HILL-ROM: OPERATING SEGMENTS
TABLE 90. JARVIK HEART: COMPANY SNAPSHOT
TABLE 91. PHILIPS: COMPANY SNAPSHOT
TABLE 92. PHILIPS: OPERATING SEGMENTS
TABLE 93. LIVANOVA: COMPANY SNAPSHOT
TABLE 94. LIVANOVA: OPERATING SEGMENTS
TABLE 95. MEDTRONIC: COMPANY SNAPSHOT
TABLE 96. MEDTRONIC: OPERATING SEGMENTS
TABLE 97. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 98. NIHON KOHDEN: OPERATING SEGMENTS
TABLE 99. RELIANTHEART: COMPANY SNAPSHOT
TABLE 100. SCHILLER: COMPANY SNAPSHOT
TABLE 101. SCHILLER: PRODUCT CATEGORIES
TABLE 102. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 103. ST. JUDE MEDICAL: PRODUCT CATEGORIES
LIST OF FIGURES
FIGURE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, CARDIAC RHYTHM MANAGEMENT MARKET, 2015
FIGURE 9. MARKET SHARE ANALYSIS, CARDIAC MONITORING MARKET, 2015
FIGURE 10. TOP IMPACTING FACTORS: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET
FIGURE 11. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET ($MILLION), 2014-2022
FIGURE 12. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 13. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 14. U.S. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 15. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 16. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 17. GERMANY CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 18. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 19. UK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 20. ITALY CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 21. SPAIN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 22. SWITZERLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 23. REST OF EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 24. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 25. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 26. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 27. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 28. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 29. NEW ZEALAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 30. REST OF ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 31. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 32. SOUTH AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 33. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 34. REST OF LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 35. ABIOMED: NET SALES, 2013-2015 ($MILLION)
FIGURE 36. BIOTRONIK: STRATEGY SHARE, (2014-2016), (%)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2013-2015, ($MILLION)
FIGURE 38. BOSTON SCIENTIFIC: STRATEGY SHARE, (2014-2016) (%)
FIGURE 39. GE: NET SALES, 2013-2015, ($MILLION)
FIGURE 40. HILL-ROM: FINANCIALS
FIGURE 41. PHILIPS: NET SALES, 2013-2015, ($MILLION)
FIGURE 42. LIVANOVA: NET SALES, 2013-2015 ($MILLION)
FIGURE 43. LIVANOVA: STRATEGY SHARE, (2014-2016), (%)
FIGURE 44. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: STRATEGY SHARE, (2014-2016),(%)
FIGURE 46. NIHON KOHDEN: FINANCIALS
FIGURE 47. RELIANTHEART: STRATEGY SHARE, (2014-2016), (%)
FIGURE 48. ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIGURE 49. ST. JUDE MEDICAL: STRATEGY SHARE, (2014-2016), (%)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
